Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being developed for type 2 diabetes treatment. This innovative peptide shows superior efficacy in glucose control and weight loss compared to similar compounds.
The molecular structure of tirzepatide features a PEG modification on the lysine side chain, enhancing water solubility while maintaining biological activity. As a dual agonist, it demonstrates greater affinity for GIP receptors than GLP-1 receptors, producing more significant reductions in hyperglycemia.
Clinical studies have demonstrated tirzepatide's effectiveness in weight management. In the SURMOUNT-1 trial, participants achieved average weight reductions of 15-20.9% after 72 weeks of treatment, depending on dosage (5mg, 10mg, or 15mg weekly). These results have led to FDA Fast Track designation for obesity treatment applications.
For research purposes, we offer high purity tirzepatide near me in convenient 10mg vials. The white powder form ensures stability and easy reconstitution for laboratory use. Our pharmaceutical-grade product undergoes rigorous quality control to guarantee 99.9% purity.
Storage recommendations include keeping the peptide in a cool, dry, dark environment and avoiding repeated freeze-thaw cycles. For optimal stability, minimize exposure to air and light, and avoid long-term storage in solution.
As a research chemical, this product is intended solely for laboratory use and not for human consumption. Researchers investigating metabolic disorders, diabetes mechanisms, or novel weight management approaches may find tirzepatide near me particularly valuable for their studies.
